enteropathogen
escherichia
coli
epec
common
caus
diarrhea
children
develop
countri
intim
adhes
bacteria
intestin
cell
occur
via
bind
adhesin
intimin
tir
receptor
expos
cell
surfac
lactobacillu
casei
express
fragment
l
caseiint
cv
test
mucos
vaccin
mice
intestin
colon
murin
pathogen
citrobact
rodentium
oral
sublingu
immun
mice
l
caseiint
cv
induc
antiint
cv
iga
fece
igg
sera
convers
antiint
cv
igg
induc
sera
mice
sublingu
immun
purifi
int
cv
vaccin
abl
decreas
c
rodentium
recoveri
fece
howev
reduct
evid
sustain
time
mice
immun
l
caseiint
cv
sublingu
rout
mice
also
display
increas
interleukin
gamma
interferon
secret
spleen
cell
day
infect
addit
oral
sublingu
immun
mice
highli
suscept
c
rodentium
infect
l
caseiint
cv
induc
antiint
cv
antibodi
significantli
increas
surviv
challeng
immunohistolog
analysi
colon
section
reveal
c
rodentium
locat
deep
fraction
tissu
mice
immun
l
casei
wherea
superfici
stain
observ
colon
section
mice
immun
l
caseiint
cv
result
indic
vaccin
compos
l
casei
express
intimin
may
repres
promis
approach
infect
model
c
rodentium
use
evalu
potenti
vaccin
epec
gastrointestin
infect
among
lead
caus
childhood
mortal
around
world
respons
approxim
million
death
everi
year
enteropathogen
escherichia
coli
epec
one
main
caus
childhood
diarrhea
develop
countri
consid
worldwid
pathogen
epec
classifi
typic
atyp
accord
express
lack
express
respect
bundleform
pilu
encod
eaf
plasmid
epidemiolog
studi
suggest
preval
atyp
epec
increas
acut
persist
diarrhea
case
children
adult
epec
colon
intestin
mucosa
caus
characterist
attach
effac
ae
lesion
format
ae
lesion
involv
type
iii
secret
system
encod
lee
pathogen
island
deliv
rang
effector
protein
host
cell
use
strategi
pathogen
trigger
actin
polymer
produc
pedestalshap
structur
bacteria
strongli
attach
interact
adhesin
intimin
transloc
receptor
tir
intimin
protein
insert
bacteri
outer
membran
typic
atyp
epec
enterohemorrhag
e
coli
ehec
mous
pathogen
citrobact
rodentium
adhesin
encod
eae
gene
essenti
virul
ntermin
region
conserv
among
intimin
wherea
ctermin
portion
highli
variabl
use
classifi
intimin
type
relat
tropism
differ
intestin
tissu
among
subtyp
one
intimin
frequent
express
epec
isol
epec
ehec
infect
prevent
breastfeed
antibodi
intimin
usual
observ
milk
women
live
area
endem
addit
antibodi
abl
inhibit
adhes
epec
epitheli
cell
vitro
sever
vaccin
strategi
use
intimin
reduc
colon
mortal
anim
model
infect
rabbit
enteropathogen
e
coli
repec
ehec
c
rodentium
suggest
intimin
good
candid
formul
vaccin
infect
minim
intimin
fragment
abl
bind
receptor
tir
compos
last
amino
acid
highaffin
bind
observ
larger
fragment
compris
last
amino
acid
residu
int
fact
subcutan
immun
mice
int
fragment
reduc
intestin
colon
c
rodentium
strain
express
intimin
subtyp
howev
analysi
immunodomin
region
insid
int
shown
antibodi
fragment
direct
region
n
terminu
int
precis
region
locat
first
amino
acid
region
amino
acid
int
moreov
human
colostrum
sampl
specif
recogn
fragment
ctermin
region
int
indic
natur
exposur
intiminbear
pathogen
elicit
antibodi
reactiv
ntermin
region
int
develop
mucos
vaccin
requir
design
immunogen
safe
vaccin
prevent
infect
reduc
transmiss
given
pathogen
mucos
vaccin
offer
mani
advantag
like
easi
administr
may
contribut
lower
cost
mass
immun
low
risk
individu
contamin
allow
needlefre
administr
induct
immun
respons
activ
pathogen
entri
site
previou
work
alreadi
test
attenu
pathogen
salmonella
enterica
vibrio
cholera
live
vector
mucos
deliveri
intimin
safer
altern
deliv
antigen
mucos
site
use
lactic
acid
bacteria
live
vector
strategi
success
appli
differ
antigen
anim
experiment
previou
studi
show
lactobacillu
casei
express
intimin
fragment
contain
immunodomin
epitop
int
induc
specif
antibodi
mice
nasal
immun
antibodi
abl
bind
epec
surfac
inhibit
bacteri
adhes
epitheli
cell
vitro
confirm
function
antibodi
intimin
fragment
contain
ntermin
region
int
present
work
analyz
abil
one
recombin
bacteria
l
caseiint
cv
pure
recombin
intimin
fragment
int
cv
induc
humor
cellular
immun
respons
mice
oral
sublingu
sl
immun
moreov
protect
potenti
vaccin
analyz
challeng
immun
mice
murin
pathogen
c
rodentium
bacteri
strain
antigen
growth
condit
recombin
l
casei
l
caseiint
cv
express
fragment
contain
conserv
plu
variabl
region
int
cv
amino
acid
previous
describ
int
cv
express
strain
intracellular
protein
observ
supernat
growth
condit
use
measur
western
blot
use
antiint
cv
antibodi
data
shown
addit
reactiv
antiint
cv
antibodi
protein
expos
l
caseiint
cv
surfac
observ
data
shown
amount
protein
express
estim
ng
per
bacteria
l
caseiint
cv
control
strain
bear
empti
express
vector
l
casei
grown
mr
difco
mi
contain
gml
erythromycin
without
shake
recombin
int
cv
express
e
coli
salt
induc
si
purifi
affin
chromatographi
previous
describ
c
rodentium
grown
luriabertani
broth
lb
difco
constant
shake
colon
experi
fece
sampl
homogen
plate
macconkey
agar
difco
plate
incub
h
c
rodentium
cfu
count
bacteri
stock
maintain
respect
cultur
media
contain
glycerol
immun
mice
femal
specificpathogenfre
spf
mice
week
old
anim
per
group
obtain
jackson
laboratori
bar
harbor
anim
facil
universidad
feder
de
paulo
cedem
convent
mice
obtain
anim
facil
faculdad
de
medicina
universidad
de
paulo
mice
suppli
food
water
ad
libitum
experiment
procedur
previous
approv
ethic
committe
anim
experiment
instituto
butantan
licens
number
univers
californiasan
diego
ucsd
institut
anim
care
use
committe
start
immun
protocol
preimmun
sera
fece
collect
analyz
presenc
antibodi
react
int
cv
enzymelink
immunosorb
assay
elisa
anim
present
posit
reaction
use
experi
immun
recombin
l
casei
bacteria
grown
late
stationari
phase
optic
densiti
nm
od
collect
centrifug
g
min
room
temperatur
wash
twice
suspend
salin
cfuml
oral
immun
cfuml
sl
immun
prior
oral
immun
mice
receiv
sodium
bicarbon
l
salin
oral
gavag
mice
immun
oral
rout
day
cfu
l
caseiint
cv
l
casei
l
salin
use
gavag
control
mice
receiv
l
salin
sl
immun
mice
anesthet
intraperiton
inject
xylazin
ketamin
l
salin
group
receiv
cfu
l
casei
l
caseiint
cv
l
salin
day
addit
group
receiv
g
purifi
int
cv
day
control
mice
receiv
salin
immun
int
cv
excess
lipopolysaccharid
lp
remov
purifi
protein
triton
extract
final
amount
lp
prepar
determin
limulu
amebocyt
lysat
test
endotoxin
unitsg
protein
vaccin
deliv
help
micropipett
tongu
direct
toward
floor
mouth
mice
maintain
head
still
flex
min
subcutan
immun
use
control
capac
int
cv
fragment
reduc
c
rodentium
colon
mice
see
supplement
materi
measur
antibodi
elisa
fourteen
day
last
immun
blood
collect
mice
retrorbit
bleed
sera
collect
incub
sampl
min
follow
incub
min
centrifug
g
min
clot
remov
sera
store
use
fece
collect
day
weigh
homogen
final
concentr
mgml
pb
contain
nonfat
dri
milk
order
avoid
nonspecif
reactiv
elisa
proteas
inhibitor
cocktail
sigma
st
loui
mo
sampl
centrifug
g
min
supernat
store
use
antibodi
evalu
elisa
use
e
coliproduc
recombin
int
cv
coat
gml
horseradish
peroxidas
hrp
conjug
goat
antimous
igg
antimous
iga
southern
biotech
birmingham
al
standard
curv
gener
use
mous
igg
iga
southern
biotech
detect
supernat
spleen
cell
cultur
elisa
spleen
obtain
immun
mice
anim
per
group
day
challeng
c
rodentium
describ
cell
suspens
prepar
rpmi
medium
gibco
carlsbad
ca
previous
describ
cellsml
plate
plate
cell
stimul
h
gml
int
cv
co
volvol
period
supernat
collect
store
later
quantif
gamma
interferon
interleukin
secret
evalu
sandwich
elisa
peprotech
rocki
hill
nj
result
express
concentr
cytokin
observ
supernat
stimul
cell
subtract
cytokin
level
nonstimul
cultur
infect
mice
c
rodentium
c
rodentium
grown
lb
h
cultur
dilut
fresh
medium
bacteria
incub
optic
densiti
follow
cultur
reach
od
bacteria
centrifug
wash
suspend
concentr
cfuml
salin
mice
infect
day
last
immun
l
bacteri
suspens
cfu
oral
gavag
fecal
pellet
collect
individu
day
challeng
weigh
homogen
l
steril
salin
serial
dilut
fecal
homogen
plate
onto
macconkey
agar
difco
cfu
determin
incub
h
minim
limit
detect
cfug
fece
infect
mice
mice
per
group
perform
way
surviv
record
day
c
rodentium
coloni
distinguish
morpholog
repres
coloni
experi
submit
pcr
analysi
use
specif
primer
amplif
result
confirm
ident
c
rodentium
coloni
immunohistolog
analysi
nine
day
c
rodentium
infect
immun
mice
euthan
colon
remov
time
point
chosen
clear
differ
state
health
mice
immun
control
group
observ
colon
open
longitudin
prepar
swiss
roll
fixat
fix
tissu
embed
paraffin
section
prepar
section
deparaffin
incub
h
pb
min
room
temperatur
inactiv
endogen
peroxidas
sampl
block
pb
contain
bovin
serum
albumin
bsa
min
room
temperatur
incub
h
buffer
contain
dilut
polyclon
rabbit
antiintimin
iggenrich
fraction
section
wash
three
time
pb
incub
h
room
temperatur
biotinlabel
goat
antirabbit
igg
sigma
dilut
bsa
sampl
wash
incub
min
extravidinperoxidas
sigma
section
develop
h
trishcl
ph
counterstain
gill
hematoxylin
sigma
slide
analyz
help
light
microscop
dmlb
leica
photograph
taken
magnif
statist
analysi
differ
surviv
time
analyz
kaplanmei
surviv
curv
differ
antibodi
concentr
c
rodentium
load
fece
analyz
mannwhitney
u
test
differ
cytokin
secret
spleen
cell
analyz
oneway
analysi
varianc
anova
follow
tukey
test
case
p
valu
consid
significantli
differ
induct
antibodi
immun
mice
recombin
l
casei
int
cv
start
immun
experi
determin
perman
recombin
l
casei
l
caseiint
cv
intestin
mucosa
mice
determin
recoveri
erythromycinresist
coloni
fece
recombin
l
casei
l
caseiint
cv
could
recov
fece
h
singl
oral
inocul
point
erythromycinresist
coloni
observ
differ
observ
inocul
l
casei
l
caseiint
cv
data
shown
mice
immun
oral
sl
rout
l
caseiint
cv
sl
rout
recombin
int
cv
fragment
accord
protocol
describ
scheme
present
fig
control
mice
immun
l
casei
salin
level
antiint
cv
iga
detect
fece
collect
day
last
immun
shown
fig
b
oral
sl
immun
mice
l
caseiint
cv
induc
significantli
higher
level
antiint
cv
iga
fece
mice
receiv
salin
l
casei
oral
immun
p
p
mice
receiv
l
caseiint
cv
compar
mice
receiv
salin
l
casei
respect
sl
immun
p
p
mice
receiv
l
caseiint
cv
compar
mice
receiv
salin
l
casei
respect
hand
induct
antiint
cv
iga
observ
fece
mice
immun
int
cv
sl
rout
fig
convers
evalu
antiint
cv
igg
sera
fig
mice
immun
differ
formul
reveal
sl
vaccin
int
cv
induc
significantli
higher
concentr
antibodi
mice
receiv
salin
fig
p
system
induct
antiint
cv
igg
observ
sera
mice
immun
l
caseiint
cv
oral
fig
sl
fig
rout
decreas
c
rodentium
colon
immun
mice
l
caseiint
cv
int
cv
test
effect
l
caseibas
vaccin
murin
model
c
rodentium
infect
decid
valid
use
int
cv
fragment
antigen
c
rodentium
colon
previou
work
ghaemmaghami
collabor
show
subcutan
immun
mice
fragment
contain
carboxytermin
amino
acid
protein
int
induc
specif
immun
respons
significantli
reduc
colon
colon
c
rodentium
strain
express
thu
perform
experi
subcutan
immun
mice
int
cv
fragment
immun
induc
significantli
higher
concentr
antiint
cv
iga
fece
p
well
antiint
cv
igg
sera
p
inocul
salin
see
fig
b
supplement
fig
immun
challeng
mice
c
rodentium
oral
immun
perform
use
gavag
mice
receiv
salin
l
casei
cfu
l
caseiint
cv
cfu
three
consecut
day
interv
total
dose
sl
immun
perform
three
dose
salin
l
casei
cfu
l
caseiint
cv
cfu
int
cv
g
fifteen
day
last
immun
mice
challeng
cfu
c
rodentium
oral
rout
colon
surviv
follow
mice
respect
antiint
cv
antibodi
measur
blood
fece
challeng
fece
differ
period
challeng
secret
cytokin
spleen
cell
collect
endpoint
colon
experi
day
challeng
measur
mice
immun
sl
rout
evalu
c
rodentium
challeng
immun
mice
reveal
significantli
lower
level
bacteria
recov
mous
fece
observ
mice
inocul
salin
reduct
observ
point
evalu
day
p
p
p
see
fig
b
c
respect
supplement
materi
level
c
rodentium
recoveri
fece
mice
control
immun
group
drastic
reduc
day
postinfect
impair
analysi
effect
induc
vaccin
therefor
use
endpoint
subsequ
experi
group
mice
inocul
salin
immun
l
casei
l
caseiint
cv
oral
sl
rout
challeng
c
rodentium
day
last
immun
fece
collect
determin
interv
cfu
evalu
plate
sampl
onto
macconkey
agar
oral
immun
mice
l
caseiint
cv
led
signific
reduct
c
rodentium
recoveri
fece
day
challeng
compar
control
group
receiv
salin
p
day
p
day
l
casei
p
day
p
day
fig
b
howev
day
challeng
reduct
observ
less
evid
recoveri
c
rodentium
point
significantli
differ
observ
mice
receiv
salin
p
fig
point
mice
display
mark
reduct
c
rodentium
load
fece
recov
infect
data
shown
similarli
sl
immun
mice
l
caseiint
cv
led
signific
decreas
c
rodentium
recoveri
fece
day
p
compar
mice
receiv
salin
p
p
compar
mice
receiv
salin
l
casei
respect
fig
e
moreov
mice
inocul
l
caseiint
cv
sl
rout
still
display
signific
reduct
fecal
load
c
rodentium
compar
mice
inocul
salin
p
l
casei
p
day
challeng
fig
notabl
least
anim
group
immun
l
caseiint
cv
c
rodentium
recoveri
limit
detect
throughout
experi
fig
f
sublingu
immun
mice
recombin
fragment
int
cv
induc
signific
reduct
c
rodentium
recoveri
fece
compar
mice
inocul
salin
day
infect
p
fig
howev
time
point
cfu
level
statist
differ
observ
mice
inocul
salin
fig
f
observ
experi
perform
oral
immun
mice
recov
infect
day
display
mark
reduct
c
rodentium
colon
data
shown
immun
respons
c
rodentium
challeng
mice
immun
sl
rout
l
caseiint
cv
vaccin
pro
duce
best
effect
reduct
c
rodentium
colon
mous
model
therefor
decid
use
condit
investig
immun
respons
immun
mice
elicit
challeng
c
rodentium
profil
antiint
cv
iga
respons
fece
mice
immun
l
caseiint
cv
sl
rout
differ
time
point
infect
c
rodentium
shown
tabl
significantli
higher
level
antiint
cv
iga
fece
observ
mice
immun
l
caseiint
cv
challeng
p
p
compar
mice
inocul
salin
l
casei
respect
h
p
compar
mice
inocul
salin
l
casei
well
day
p
compar
mice
inocul
salin
l
casei
challeng
tabl
antiint
cv
iga
detect
fece
mice
immun
l
caseiint
cv
sl
rout
reach
mean
concentr
ngml
h
challeng
slightli
higher
mean
concentr
detect
challeng
ngml
although
decreas
rout
two
week
last
administr
group
challeng
c
rodentium
fece
sampl
collect
day
b
e
c
f
challeng
plate
c
rodentium
cfu
count
zero
repres
cfu
detect
minim
limit
detect
cfug
fece
asterisk
indic
data
significantli
differ
observ
mice
inocul
salin
p
day
day
p
day
oral
immun
p
day
l
caseiint
cv
int
cv
respect
p
day
day
sl
immun
indic
data
significantli
differ
observ
mice
inocul
l
casei
p
day
day
oral
immun
p
day
day
sublingu
immun
statist
analys
perform
mannwhitney
u
test
result
repres
least
two
experi
antiint
cv
iga
detect
observ
day
challeng
concentr
still
significantli
higher
sampl
collect
mice
immun
l
caseiint
cv
mice
immun
l
casei
salin
reduct
detect
antiint
cv
iga
observ
reach
mean
concentr
ngml
day
challeng
convers
antiint
cv
iga
concentr
mice
inocul
salin
reach
mean
valu
ngml
day
infect
tabl
significantli
lower
level
c
rodentium
could
recov
fece
mice
immun
l
caseiint
cv
mice
inocul
salin
l
casei
reduct
statist
signific
h
infect
compar
mice
immun
l
casei
p
statist
signific
day
p
p
infect
compar
mice
inocul
salin
tabl
besid
induct
antibodi
cytokin
report
particip
control
infect
ae
pathogen
therefor
decid
analyz
possibl
induct
cytokin
l
caseiint
cv
sl
vaccin
secret
evalu
spleen
cell
collect
mice
immun
l
caseiint
cv
stimul
vitro
int
cv
howev
due
variabl
observ
among
anim
result
inconclus
data
shown
decid
analyz
secret
cytokin
spleen
cell
collect
immun
mice
day
challeng
c
rodentium
endpoint
colon
experi
stimul
vitro
int
cv
cell
mice
immun
l
caseiint
cv
vaccin
sl
rout
show
signific
increas
secret
day
c
rodentium
infect
compar
cell
mice
inocul
l
casei
p
salin
p
fig
moreov
level
also
significantli
higher
level
observ
cell
obtain
anim
immun
int
cv
p
hand
level
secret
cell
collect
mice
immun
int
cv
statist
differ
level
secret
cell
collect
mice
receiv
salin
secret
spleen
cell
also
evalu
mice
immun
sl
rout
day
challeng
c
rodentium
highest
level
secret
observ
cell
mice
immun
l
caseiint
cv
result
significantli
differ
observ
cell
mice
immun
l
casei
p
inocul
salin
p
fig
although
higher
level
secret
also
observ
cell
collect
mice
immun
int
cv
fragment
sl
rout
result
statist
differ
level
secret
cell
anim
receiv
salin
fig
l
caseiint
cv
vaccin
extend
surviv
time
hepa
mice
c
rodentium
challeng
effect
l
caseiint
cv
vaccin
oral
sl
rout
evalu
mous
strain
highli
suscept
c
rodentium
infect
perman
l
casei
l
caseiint
cv
intestin
mucosa
mice
determin
describ
mice
result
show
l
casei
l
caseiint
cv
could
recov
fece
h
singl
inocul
time
point
erythromycinresist
l
casei
coloni
observ
fece
differ
observ
two
l
casei
strain
data
shown
immun
mice
l
caseiint
cv
oral
rout
induc
significantli
higher
concentr
antiint
cv
iga
fece
immun
mice
l
casei
p
fig
howev
concentr
antiint
cv
igg
observ
sera
mice
immun
formul
statist
differ
fig
sublingu
immun
mice
l
caseiint
cv
instead
induc
significantli
higher
level
antiint
cv
iga
fece
p
fig
igg
sera
p
fig
mice
immun
l
casei
mice
immun
formul
oral
sl
rout
challeng
c
rodentium
surviv
follow
day
group
receiv
l
caseiint
cv
oral
rout
show
signific
increas
mean
surviv
time
challeng
compar
group
immun
l
casei
p
fig
mice
immun
oral
rout
l
casei
die
day
infect
mice
surviv
total
mice
mice
immun
l
caseiint
cv
die
day
infect
day
infect
three
mice
total
mice
remain
aliv
none
display
sign
diseas
similarli
immun
mice
l
caseiint
cv
sl
rout
significantli
extend
mean
surviv
time
group
compar
immun
mice
l
casei
p
mice
receiv
l
casei
sl
rout
die
day
mice
surviv
total
mice
major
anim
l
caseiint
cv
group
die
day
mice
surviv
total
mice
fig
howev
case
mice
surviv
challeng
section
colon
mice
immun
oral
sl
rout
l
casei
l
caseiint
cv
prepar
day
infect
stain
detect
c
rodentium
time
point
differ
observ
anim
l
casei
l
caseiint
cv
group
regard
sign
diseas
evid
colon
section
collect
infect
mice
posit
c
rodentium
stain
fig
j
howev
damag
intestin
epithelium
clearli
advanc
stage
mice
immun
l
casei
oral
sl
rout
day
challeng
stage
c
rodentium
stain
observ
deep
region
crypt
fig
f
convers
mice
immun
l
caseiint
cv
display
preserv
structur
intestin
epithelium
c
rodentium
stain
observ
superfici
layer
fig
j
specif
stain
observ
uninfect
mice
use
control
fig
b
oral
vaccin
gastrointestin
infect
usual
requir
deliveri
system
abl
protect
antigen
aggress
environ
found
mucosa
sever
strategi
design
optim
antigen
present
induct
immun
respons
may
improv
protect
lactic
acid
bacteria
resist
passag
gastrointestin
tract
usual
safe
administ
mucos
rout
potenti
express
heterolog
antigen
characterist
make
attract
altern
develop
mucos
live
vaccin
l
casei
strain
express
sever
heterolog
antigen
test
vaccin
anim
model
promis
result
previou
work
engin
l
casei
express
int
cv
fragment
l
caseiint
cv
nasal
immun
mice
recombin
l
casei
elicit
antibodi
abl
bind
epec
surfac
inhibit
bacteri
adhes
epitheli
cell
vitro
efficaci
subcutan
immun
mice
int
cv
fragment
colon
murin
pathogen
c
rodentium
shown
present
work
confirm
protect
potenti
fragment
vivo
l
caseiint
cv
therefor
test
live
oral
sl
vaccin
mice
infect
c
rodentium
sl
rout
use
mani
year
effect
way
deliv
lowmolecularweight
drug
small
immunogen
peptid
elicit
system
respons
mainten
formul
sl
mucosa
prior
swallow
allow
antigen
uptak
dendrit
cell
present
thin
sl
epithelium
modul
immun
system
administr
differ
lactobacillu
speci
sl
rout
mice
describ
especi
anim
model
allergi
howev
use
rout
vaccin
use
recombin
lactic
acid
bacteria
express
heterolog
antigen
less
explor
oral
sl
immun
mice
l
caseiint
cv
induc
significantli
higher
concentr
antiint
cv
igg
sera
control
still
vaccin
mice
display
significantli
higher
concentr
antiint
cv
iga
fece
studi
literatur
report
induct
antiintimin
iga
gut
mucos
site
especi
mucos
immun
effect
usual
requir
use
potent
adjuv
attenu
pathogen
shown
l
caseiint
cv
vaccin
formul
capabl
induc
specif
iga
respons
gut
mucosa
site
infect
pathogen
caus
ae
lesion
without
use
addit
adjuv
present
work
use
l
casei
strain
express
int
cv
fragment
intracellular
compart
differ
work
test
efficaci
lactobacilli
vaccin
vector
express
heterolog
antigen
differ
locat
comparison
lactobacillu
plantarum
express
c
fragment
tetanu
toxin
differ
cellular
locat
intracellular
secret
cell
surfac
expos
reveneau
collabor
conclud
immun
mice
oral
intranas
rout
strain
express
protein
intracellularli
best
way
induc
specif
system
mucos
antibodi
hand
intracellular
express
int
cv
effici
induc
antibodi
mice
strain
express
antigen
expos
cell
surfac
may
relat
undesir
process
antigen
attach
cell
wall
result
releas
great
part
heterolog
protein
growth
medium
unpublish
data
group
case
l
caseiint
cv
strain
captur
bacteria
antigenpres
cell
mucos
surfac
occur
result
present
int
cv
peptid
major
histocompat
complex
mhc
class
ii
molecul
induct
antibodyproduc
cell
context
common
mucos
immun
system
cmi
secret
antibodi
distant
effector
site
well
induct
system
antibodi
occur
sublingu
immun
exampl
take
place
challeng
immun
mice
show
l
caseiint
cv
oral
sl
vaccin
significantli
decreas
intestin
colon
c
rodentium
effect
evid
mice
receiv
l
caseiint
cv
sl
rout
group
show
decreas
c
rodentium
recoveri
fece
day
infect
day
challeng
work
evalu
bacteri
colon
intestin
tissu
mice
colon
cecum
would
hamper
analysi
colon
kinet
anim
previou
work
wile
collabor
use
bioluminesc
imag
follow
c
rodentium
use
bioluminesc
strain
deriv
strain
infect
mice
observ
pattern
similar
observ
present
work
accord
result
highest
vivo
signal
bacteri
infect
could
detect
day
postinfect
accompani
plateau
bacteri
shed
stool
bioluminesc
start
decreas
day
postinfect
low
signal
observ
one
anim
day
postinfect
moreov
tight
correl
bioluminesc
cfu
count
obtain
stool
observ
result
confirm
bacteri
recoveri
fece
reflect
burden
c
rodentium
infect
mice
support
analysi
previou
work
maaser
collabor
show
clearanc
c
rodentium
colon
nonimmun
mice
depend
presenc
igg
bacteria
administr
sera
mice
recov
c
rodentium
colon
protect
mice
infect
howev
igg
deplet
sera
protect
longer
observ
sublingu
immun
mice
purifi
int
cv
fragment
induc
significantli
higher
concentr
antiint
cv
igg
sera
antiint
cv
iga
fece
vaccin
significantli
reduc
c
rodentium
recoveri
fece
fourth
day
challeng
howev
reduct
maintain
follow
day
collect
compar
mice
inocul
salin
possibl
level
igg
induc
high
enough
maintain
low
level
colon
fragment
inocul
subcutan
rout
antiint
cv
igg
concentr
sera
around
time
higher
observ
mice
immun
sl
rout
similar
amount
antiint
cv
observ
immun
ratio
subcutan
sl
immun
respect
indic
balanc
profil
howev
subcutan
immun
int
cv
elicit
significantli
higher
concentr
antiint
cv
iga
thu
higher
level
total
antiint
cv
igg
sera
induct
signific
level
antiint
cv
iga
fece
may
contribut
reduct
c
rodentium
recoveri
fece
subcutan
immun
mice
throughout
experi
see
supplement
materi
hand
l
casei
system
protect
elicit
l
caseiint
cv
vaccin
observ
even
condit
signific
induct
antiint
cv
igg
sera
detect
addit
antiint
cv
igg
detect
mous
fece
data
shown
data
impli
mechan
involv
protect
elicit
l
caseiint
cv
oral
sl
vaccin
kinet
iga
induct
c
rodentium
cfu
recoveri
fece
suggest
local
antiint
cv
iga
respons
induc
l
caseiint
cv
sl
vaccin
may
contribut
lower
number
bacteria
observ
earli
phase
infect
prevent
reduc
initi
attach
bacteria
epitheli
gut
detect
antibodi
progress
less
infect
one
possibl
explan
observ
may
relat
consumpt
turnov
antibodi
infect
interestingli
group
mice
inocul
salin
antiint
cv
iga
fece
could
detect
day
challeng
c
rodentium
time
point
preced
clearanc
bacteria
model
group
describ
induct
mucos
system
antibodi
c
rodentium
antigen
includ
intimin
mice
follow
bacteri
clearanc
despit
observ
abl
determin
signific
neg
correl
c
rodentium
recoveri
fece
concentr
antiint
cv
iga
similar
result
report
khare
colleagu
show
oral
vaccin
base
attenu
salmonella
enterica
express
intimin
abl
induc
iga
fece
reduc
e
coli
shed
cattl
studi
magnitud
bacteri
shed
also
neg
correl
level
antiintimin
iga
dann
collabor
demonstr
cytokin
play
import
role
intestin
defens
ae
pathogen
mice
fail
control
c
rodentium
intestin
colon
display
increas
apoptosi
epitheli
colon
cell
subsequ
ulcer
infect
higher
mortal
rate
observ
mice
wildtyp
mice
infect
human
epitheli
colon
cell
epec
strain
activ
nfb
transcript
factor
key
element
regul
gene
transcript
togeth
result
suggest
mechan
express
bacteri
intestin
infect
work
similarli
human
mice
play
import
role
protect
pathogen
experi
signific
increas
secret
spleen
cell
day
challeng
observ
mice
immun
l
caseiint
cv
sl
rout
group
show
best
reduct
c
rodentium
colon
addit
secret
spleen
cell
also
significantli
higher
group
mice
control
group
cytokin
also
describ
key
factor
protect
pathogen
express
increas
cell
colon
mice
infect
c
rodentium
immun
mous
strain
highli
suscept
c
rodentium
infect
oral
sl
l
caseiint
cv
vaccin
significantli
extend
surviv
mice
challeng
sl
vaccin
induc
significantli
higher
level
antiint
cv
igg
sera
iga
fece
mice
wherea
oral
vaccin
induc
slightli
higher
concentr
antiint
cv
igg
sera
significantli
higher
level
antiint
cv
iga
fece
c
rodentium
infect
caus
inflamm
colon
mucosa
mice
effect
particularli
sever
promin
submucos
edema
epitheli
damag
crypt
hyperplasia
goblet
cell
deplet
analysi
colon
section
obtain
mice
immun
rout
day
challeng
reveal
mice
receiv
l
caseiint
cv
vaccin
show
less
epitheli
damag
ulcer
time
point
l
caseivaccin
mice
c
rodentium
stain
local
superfici
intestin
epithelia
mice
immun
l
caseiint
cv
wherea
bacteri
stain
observ
deep
region
intestin
crypt
mice
immun
l
casei
howev
later
sever
eros
epitheli
damag
l
caseiint
cv
vaccin
mice
probabl
reach
level
observ
colon
section
l
caseivaccin
anim
sinc
almost
mice
succumb
infect
summari
investig
protect
potenti
l
caseiint
cv
two
mucos
rout
murin
pathogen
c
rodentium
result
suggest
l
caseiint
cv
formul
could
repres
promis
strategi
develop
mucos
vaccin
ae
pathogen
particular
sl
rout
administr
induc
specif
respons
iga
igg
secret
shown
group
import
protect
pathogen
sl
l
caseiint
cv
vaccin
show
good
protect
level
mous
model
c
rodentium
infect
fewer
immun
dose
togeth
present
result
indic
develop
mucos
vaccin
base
l
casei
express
intimin
worthwhil
strategi
pathogen
caus
ae
lesion
